Raptor Pharma (RPTP) Reports Better-Than-Expected Q3 Loss of 6c/Share

Raptor Pharma (NASDAQ: RPTP) reported Q3 EPS of ($0.06), $0.12 better than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Raptor Pharm (RPTP) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat
• Star Equity to acquire Harte Hanks for $5 per share in cash and stock